ASX 200
Checkout Our Recommendations for free - 7 day free trial Subscribe Now

Abbott Laboratories - ABT share price

Current Price: $ - -
Updated At: -

About

Abbott Laboratories is a global healthcare company. The Company is engaged in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. The Company operates through four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment is engaged in the international sales of a broad line of branded generic pharmaceutical products. The Diagnostic Products segment is engaged in the worldwide sales of diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Nutritional Products segment is involved in the worldwide sales of a broad line of adult and pediatric nutritional products. The Medical Devices segment includes the worldwide sales of rhythm management, electrophysiology, heart failure, vascular, structural heart, neuromodulation, and diabetes care products.

Company Profile

Market Cap: -
Enterprise Value: -
Shares Outstanding: -
Shares Float: -
P/E Ratio: -
PEG Ratio: -
Book Value: -
Revenue TTM: -
Div Yield: -
Earning Share: -
Dividend per Share: -
Profit Margin: -

Disclaimer: The above financial data is sourced from EODHD and is for informational purposes only. Veye does not guarantee the accuracy or completeness of this data. Investors should conduct their own research and consult with a financial advisor before making investment decisions.

Top Shareholders

Price Summary

Today's High -
Price High
Today's Low -
Price Low
52 Week High: -
Price High
52 Week Low: -
Price Low
Price High
Week's High: -
Price Low
Week's Low: -

Price Chart

Get Your FREE Report

Discover the Top ASX Stocks to Invest In 2026!

Expert Analysis of Top-Performing ASX Stocks

Market Insights and In-Depth Research

Buy, Sell, And Hold Recommendations

Almost There!

Enter your details to download the report

Success!

Preparing your download...

Latest Reports from Veye

Grab Your FREE Report on Top 5 ASX Stocks to Buy in 2026